Oncologic Emergency Medicine Fellowship
The Oncologic Emergency Medicine fellowship provides advanced training in the emergency treatment of cancer patients to board-certified or board-eligible emergency medicine/internal medicine physicians in the practice of oncologic emergency medicine. The main goal of the program is to facilitate expertise in the diagnosis, treatment, and multidisciplinary management of cancer patients presenting to the emergency department as well as to advance scholarship in the growing subdiscipline of oncologic emergency medicine. The duration of the program is 12 months from July 1 through June 30 with the option of a second year.
At the completion of the first year of training, the fellow is expected to be knowledgeable about appropriate diagnostic and therapeutic approaches to cancer patients who present to the emergency department for acute care. Each fellow will have exposure to a variety of clinical research projects and will participate and produce an abstract or manuscript. As a result of this training, the fellow will be recognized as an expert in the emerging discipline of oncologic emergency medicine.
Fellowship application process:
Eligible candidates should have completed an ACGME-accredited residency program in Emergency Medicine or Internal Medicine or an equivalent international program if outside the U.S. Personal statements, curriculum vitae, and three letters of recommendation are required as well as meeting the institutional eligibility requirements. If currently in training, one letter should come from the program director, and indicate standing and expected completion of training. Competitive candidates will be asked for medical school transcripts and invited for personal interviews. Applications should be sent to:
Kumar Alagappan, M.D.
Professor and Chair, ad interim
Emergency Medicine department, Unit 1468
The University of Texas MD Anderson Cancer Center
PO Box 301402
Houston, TX 77030-1402
Or send via email to email@example.com.
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.